FDA halts actions on makers of compounded drugs as it reviews decision to remove Eli Lilly's (LLY) weight loss drug ...

The FDA, in a stark reversal, on Friday said it would reconsider its decision to remove Eli Lilly’s tirzepatide, from its ...

The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...

Michigan's Supreme Court reexamines rulings that may affect how the state's consumer protection laws apply to insulin pricing ...

The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...

The $200B GLP-1 market is set to expand with 16 new obesity drugs launching by 2029, challenging Novo Nordisk and Eli Lilly's dominance while addressing scalability and pricing concerns.

In recent years, the pharmaceutical manufacturer has seen dizzying growth in its pipeline for a wide range of diseases. And ...

A Washington-based surgery center ranked by a nonprofit among the top in the state for minor gender reassignment surgeries ...

LOUISVILLE, Ky. (WDRB) -- Indiana Gov. Eric Holcomb will lead a U.S. delegation to Greece next week at the invitation of the ...

Gov. Eric Holcomb will lead an international trip to the Hellenic Republic, better known as Greece, next week at the ...

Peptide companies' are creating knock-off versions of these drugs that have not been approved by the FDA and contain ...